The 5-HT 1A receptor is a prototypical member of the large and diverse serotonin receptor family. One key role of this receptor is to stimulate cell proliferation and differentiation via the extracellular signal regulated protein kinase (ERK) mitogen activated protein (MAP) kinase. There are few reports on the ability of the 5-HT 1A receptor to modulate other MAP kinases such as c-Jun N-terminal kinase (JNK), which is activated by various extracellular stimuli, resulting in cell growth, differentiation, and programmed cell death. We report here for the first time that the 5-HT 1A receptor stimulates JNK. JNK stimulation was Pertussis toxin-sensitive and was mediated by Rho family low molecular weight GTPases. The 5-HT 1A receptor also increased apoptosis, which was mimicked by the MEK inhibitor PD98059, and blocked by the JNK inhibitor SP600125. These results suggest that the 5-HT 1A receptor stimulates both ERK-dependent anti-apoptotic pathways and JNK-dependent pro-apoptotic pathways in CHO cells.
Introduction
Monoamines (serotonin, dopamine, norepinephrine, epinephrine) serve as endogenous neurotransmitters. However, monoamines have also been implicated in the pathologies of several neurodegenerative and neuropsychiatric disorders due to their ability to induce neuronal cell death. Dopamine, in particular, has been shown to be pro-apoptotic in a number of cell types, and consequently is a major contributor to the pathophysiology of neurodegenerative diseases such as Parkin-son's disease [1] [2] [3] . Conflicting reports exist for serotonin, and this particular monoamine can apparently be either apoptotic or neuroprotective in neurons. This divergence is likely due to differences in the expression of individual 5-HT receptor subtypes in cells and/or tissues.
The 5-HT 1A receptor is arguably the best characterized of the 5-HT receptor subtypes, having been studied for well over a decade. It has been implicated in numerous physiological and pathological processes including thermoregulation [4, 5] , sexual behavior [6] , memory [7] , immune function [8] , depression [9, 10] , and anxiety [11, 12] . The 5-HT 1A receptor is a prototypical G protein-coupled receptor (GPCR), which couples to a broad array of second messengers including adenylyl cyclase [13, 14] , phospholipase C [15] , protein kinase C [16] , K + channels [17] [18] [19] , ERK mitogen-activated protein kinase [20, 21] , and Na + /H + exchange [20, 22] . Virtually all of these cellular effects are disrupted by pretreatment with Pertussis toxin (PTX), indicating that 5-HT 1A receptors couple specifically and/or preferentially to G i/o -proteins.
The 5-HT 1A receptor is generally believed to have antiapoptotic properties. In fact, some neuronal cell-types may actually up-regulate 5-HT 1A receptors under apoptosis-inducing conditions [23] . 5-HT 1A receptor agonists have been found to be effective in preventing toxin-induced apoptosis in primary hippocampal and cortical cultures [24, 25] , and in cultured neurons from chick embryo telencephalons [26] . These protective effects appear to derive from the ability of the receptor to cause K + channel-dependent membrane hyperpolarization [27] and to activate ERK MAP kinases [28, 29] .
Many GPCRs are capable of activating growth factor receptor signaling cascades such as the mitogen-activated protein kinases, ERK1 and ERK2. The 5-HT 1A receptor is no exception, and several groups have reported that the recombinant 5-HT 1A receptor can activate ERK MAP kinases in CHO cells [20, 21, [30] [31] [32] [33] . This activation is initiated by βγ-subunits released from PTX-sensitive G-proteins, and involves the nonreceptor tyrosine kinase Src and Ca 2+ /calmodulin-dependent receptor endocytosis [32] . In addition, Adayev et al. showed that the 5-HT 1A receptor utilizes ERK MAP kinases to inhibit the proapoptotic enzyme caspase-3 in hippocampal HN2-5 cells [28, 29] . However, activation of mitogen-activated protein kinases other than ERK by the 5-HT 1A receptor has yet to be investigated.
c-Jun N-terminal protein kinase (JNK) is a member of the 'stress-activated' MAP kinases. JNKs are potently activated by stress signals such as UV-or X-irradiation, heat shock, and osmotic shock, while typically being only modestly activated by polypeptide growth factors and phorbol esters. JNK family members are activated by dual phosphorylation on threonine and tyrosine residues by the upstream kinases MKK4 and MKK7, in some cases involving members of the Rho family of small molecular weight GTPases [34] . Once activated, JNK phosphorylates transcription factors such as c-Jun and ATF2. The resulting alterations in gene expression contribute to the mammalian stress response by affecting the cell cycle, DNA repair and apoptotic pathways.
The roles of JNK MAP kinases have been extensively studied, particularly in the central nervous system, where they are thought to mediate neuronal differentiation and apoptosis. In PC12 cells it was demonstrated that induction of the apoptotic death response requires activation of JNK and p38 MAP kinases, in combination with simultaneous inhibition of ERK MAP kinases [35] . Similar roles for JNK in the apoptotic response have been outlined in sympathetic neurons [36] and SH-SY5Y human neuroblastoma cells [37] , as well as non-neuronal small cell lung carcinoma cells [38] , pancreatic β-cells [39] , and endothelial cells [40] . Thus, cellular survival and/or proliferation following an extracellular stimulus may ultimately depend on the contributions of individual MAP kinase pathways.
In the current study, we report that the 5-HT 1A receptor can activate the c-Jun NH 2 -terminal kinase (JNK) in Chinese hamster ovary (CHO) fibroblasts. This activation was rapid (within 10 min) and sustained, and resulted in increased programmed cell death marked by the formation of apoptotic bodies and the observance of DNA fragmentation. This suggests that the growth-promoting/neuroprotective and apoptosis-inducing effects of 5-HT 1A receptor activation may depend on the collective contributions of both the ERK and JNK signal transduction pathways. The relative balance between those pathways could mediate cell-specific responses of the 5-HT 1A receptor in and non-neuronal tissues.
Experimental procedures
2.1. Cell culture CHO-K1 cells expressing ≈ 50 fmol of human 5-HT 1A receptor/mg of protein (CHO-5-HT 1A R cells) were maintained in F12/HAMS medium, supplemented with 10% fetal calf serum, streptomycin (100 μg/ml), penicillin (100 units/ml), and gentamycin (400 μg/ml) at 37°C in a 5% CO 2 -enriched, humidified atmosphere. 24 to 48 h prior to each experiment, cells were switched to serum-free medium containing 0.5% bovine serum albumin (Sigma).
Phospho-ERK immunoblots
Serum-starved CHO-5-HT 1A R cells were treated with 8-OH-DPAT (10 −9 to 10 −5 M) for varying time periods (0-60 min). Cells were then scraped into Laemmli buffer and subjected to SDS-PAGE under reducing conditions. Separated proteins were transferred to PVDF membranes and incubated with an anti-phospho-ERK rabbit polyclonal antibody (Cell Signaling, Inc.; Beverly, MA), followed by incubation with an horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (Cell Signaling). Immunoreactive bands were visualized using a chemiluminescent method (CDP Star, New England BioLabs, Beverly, MA) by exposing to Kodak X-AR film. To verify equal loading, the same membranes were stripped using Re-Blot Plus (Chemicon International, Inc.; Temecula, CA) and reprobed with an anti-total ERK antibody (Cell Signaling). Each phospho-ERK value was normalized using the corresponding total ERK value to control for the possibility of differential loading.
Jun kinase assay
Jun kinase activity was determined by precipitation with agarose beads coupled to GST fusion proteins containing the JNK substrate, c-Jun, using a commercial JNK activation kit (New England Biolabs). Briefly, serum-starved cells were exposed to 8-OH-DPAT+/− other agents for the times indicated. Cells were subsequently washed with ice-cold phosphate-buffered saline (10 mM sodium phosphate, 150 mM NaCl, pH 7.4) and scraped in lysis buffer. Lysates were then sonicated four times for 5 s each and centrifuged for 10 min at 14,000×g. Clarified extracts were incubated with 2 μg of c-Jun fusion protein beads overnight at 4°C and washed twice with lysis buffer and twice with kinase buffer. The pellets were then resuspended in 50 μL of kinase buffer in the presence of 100 μM ATP, and incubated for 30 min at 30°C. Reactions were terminated by adding 50 μL of 2× SDS loading buffer, separated by SDS-PAGE, and transferred to PVDF. Membranes were subsequently incubated with a rabbit polyclonal anti-phospho-c-Jun antibody, followed by incubation with an horseradish peroxidase-conjugated goat antirabbit secondary antibody. Phosphorylated c-Jun was then detected using chemiluminescence by exposure to Kodak X-AR film. Each phospho-c-Jun value was normalized using the corresponding total c-Jun value to control for differential loading.
TUNEL staining
DNA cleavage and chromatin condensation associated with apoptosis were detected using a modified fluorescent TUNEL assay (Apoptag® Plus Fluorescein In Situ Apoptosis Detection Kit, Chemicon Intl.) according to the manufacturer's instructions. Briefly, CHO-5-HT 1A R cells were seeded on glass coverslips and cultured to approximately 50% confluence. Cells were then pretreated with 10 μM PD98059, 10 μM SP600125, or vehicle for 30 min, or PTX (200 ng/ml) overnight or toxin B (10 ng/ml for 2 h), and cultured in serum-free medium in the continued presence of those agents for 48 h either in the presence or absence of 1 μM 8-OH-DPAT. Fixation was performed in 1% paraformaldehyde/PBS, pH 7.4 for 10 min at room temperature, followed by a post-fixation in ethanol/acetic acid 2:1 for 5 min at − 20°C. Cells were then incubated with terminal deoxynucleotidyl transferase (TdT) and digoxigenin-labeled nucleotides. Specimens were then incubated with a flourescein-conjugated anti-digoxigenin antibody for 30 min at room temperature and counterstained with 2 μM propidium iodide. Cover slips were placed onto glass slides using mounting medium and viewed by fluorescence microscopy. For each sample, the number of fluorescein-positive nuclei was counted in ten high power fields.
Measurement of DNA fragmentation
Internucleosomal DNA fragmentation was assayed using an Apoptotic DNA Ladder Detection Kit (Chemicon Intl.) according to the manufacturer's instructions. Briefly, CHO-5-HT 1A R cells grown to ∼ 50% confluence were pretreated with 10 μM PD98059, 10 μM SP600125, or vehicle for 30 min, and cultured in serum-free medium in the continuing presence of those agents for 48 h either in the presence or absence of 1 μM 8-OH-DPAT. Cells were then harvested, washed in PBS, and lysed. Crude lysates were incubated with RNAse A and Proteinase K for 30 min at 37°C and chromosomal DNA was precipitated by incubation with ammonium acetate and ethanol overnight at − 20°C. The resulting DNA pellets were washed with 70% ethanol and loaded onto a 1% tris-acetate agarose gel containing 0.5 μg/ml ethidium bromide. Stained DNA was visualized by transillumination with UV light and photographed.
Statistical analysis
Results shown represent the means ± S.E. of the number of experiments indicated in every case. Statistical analysis was performed by two-tailed, paired Student's t-test.
Results

8-OH-DPAT activates ERK in CHO fibroblasts expressing the 5-HT 1A receptor
CHO cells stably transfected with the 5-HT 1A receptor cDNA have been extensively utilized as a model to study the signal transduction pathways mediated by this receptor. Using this system, several groups, including ours, have documented that the 5-HT 1A receptor can activate ERK MAP kinases [20, 21, [30] [31] [32] [33] . We previously reported that the 5-HT 1A receptor activates ERK via the release of βγ-subunits from PTXsensitive G-proteins. Stimulation of ERK proceeds through the Ras → Raf → MEK → ERK pathway, and appears to involve reactive oxygen species generation and subsequent activation of the non-receptor tyrosine kinase Src, as well as a receptor endocytosis step that requires Ca 2+ /calmodulin [32] . As shown in Fig. 1 , stimulation with 8-OH-DPAT, a high-affinity agonist selective for 5-HT 1A receptors, produced concentration-and time-dependent increases in ERK phosphorylation, which reached a maximum at approximately 100 nM ( Fig. 1A) . Phosphorylation was very rapid, reaching peak stimulation by 5 min (Fig. 1B) , followed by a relatively rapid decrease, which subsided by 60 min.
8-OH-DPAT activates JNK in CHO fibroblasts expressing the 5-HT 1A receptor
Although the coupling of the 5-HT 1A receptor to ERK has been relatively well characterized, its involvement in the activation of other MAP kinases has yet to be delineated. We were particularly interested in whether the 5-HT 1A receptor could activate p38 and/or c-Jun N-terminal kinases, as these MAP kinase family members have been closely associated with cell differentiation, proliferation, and death. Efforts by other groups to clarify this question have failed to demonstrate 5-HT 1A receptor-mediated activation of JNK or other stress-activated MAP kinases. Interestingly, Chen et al., using rat brain tissue, reported that 8-OH-DPAT was unable to modify phosphorylation of either the JNK or p38 MAP kinases [41] . However, in that study 8-OH-DPAT also failed to stimulate ERK MAP kinases, instead actually decreasing basal levels of ERK phosphorylation in a concentration-and time-dependent manner. In cultured human peripheral lymphocytes, Cloez-Tayarani et al. showed that the 5-HT 1A receptor activates ERK, but not p38 MAP kinases [42] . We assayed the ability of the 5-HT 1A receptor to activate JNK using a kinase assay in which we measured the ability of immunoprecipitated JNK to phosphorylate a GST fusion protein of c-Jun. Stimulation of CHO-5-HT 1A R cells with 8-OH-DPAT resulted in concentration-and time-dependent increases in JNK activity (Fig. 1C) , with maximal activity at a concentration of 1 μM ( Fig. 2A) . JNK activity increased within 5 min and reached a maximum at 20 min ( Fig. 1D) , with activity decreasing slowly thereafter. 8-OH-DPAT induced an approximately 3-to 4-fold increase in JNK activity, compared to an approximately 6-to 7-fold increase in ERK phosphorylation. However, maximum JNK activation (20 min) occurred later than for ERK activation (5 min), and was more sustained. We considered the possibility that the 5-HT 1A receptor might also activate p38 MAPK in these cells, but were unable to detect significant increases in p38 phosphorylation (not shown, n = 3). 
Activation of JNK by the 5-HT 1A receptor is mediated by Rho family low-molecular-weight GTPases
Rho family GTPases have been implicated in the activation of JNK by various stimuli. The 5-HT 1A receptor can activate all three major Rho family members (Rho, Rac, Cdc42) in CHO cells (Turner and Raymond, manuscript in preparation). To determine whether the 5-HT 1A receptor utilizes Rho family GTPases to activate JNK, we tested the effects of Clostridium difficile toxin B, which glucosylates and inactivates Rho family proteins without affecting Ras family members [43] . CHO cells were incubated with 10 ng/ml of toxin B for 2 h, followed by stimulation with 8-OH-DPAT for 20 min. As shown in Fig. 2C , toxin B significantly decreased the activation of JNK. In contrast toxin B had no effect on ERK phosphorylation (n = 3, not shown). These data suggest that JNK activation by the 5-HT 1A receptor is mediated, in part, by one or more members of the Rho family of low-molecular-weight GTPases.
8-OH-DPAT induces apoptotic chromatin condensation and DNA fragmentation that are JNK-dependent
JNK and other stress kinases have been linked to apoptotic cell death pathways in many cell types, including neurons. Consequently, we wondered whether 5-HT 1A receptor-mediated activation of JNK could increase apoptosis in CHO cells. Apoptotic cell death is typically preceded by the fragmentation of genomic DNA. Cells undergoing apoptosis first produce large (∼ 50-300 kb) DNA fragments via the endonucleolytic degradation of higher-order chromatin structural organization. This is closely followed by further endonucleolytic cleavage at sites between nucleosomes, ultimately resulting in the formation of ∼180 bp nucleosomal DNA fragments [44] . In order to test the possible involvement of the 5-HT 1A receptor in regulating apoptosis, CHO-5-HT 1A R cells were pretreated with the MEK inhibitor PD98059, the JNK inhibitor SP600125, or vehicle, and then cultured in serum-free medium for 48 h in the presence or absence of 1 μM 8-OH-DPAT, following which we assessed DNA fragmentation using agarose gel electrophoresis. The specificities of PD98059 and SP600125 for blocking ERK and JNK, respectively, were verified using phosphorylation state specific antibodies or kinase assays (n = 3 for both compounds, not shown). As shown in Fig. 3A , 5-HT 1A receptor activation by 8-OH-DPAT increased DNA fragmentation both in vehicle-pretreated and PD98059-pretreated cells. In contrast, agonist-induced DNA fragmentation was inhibited almost completely in cells pretreated with the JNK inhibitor SP600125. These results suggest that the 5-HT 1A receptor regulates apoptosis in CHO cells. Using the same experimental treatment conditions, we next assessed apoptosis using the TUNEL assay, which detects DNA strand breaks by enzymatically labeling free 3′-OH termini with digoxigenin-labeled nucleotides. Enzymatically labeled 3′-OH termini were detected with a fluoresceinconjugated anti-digoxigenin antibody, and cell nuclei were counterstained with propidium iodide. As shown in Fig. 3B,  8 -OH-DPAT-treated cells contained an increased number of nuclei with condensed chromatin, as assayed by propidium iodide staining. Likewise, these nuclei were also TUNELpositive, indicating that the cells were undergoing apoptosis. These data are represented graphically in Fig. 3C . The number of TUNEL(+) nuclei was increased in cells treated with 8-OH-DPAT by approximately 2.5-fold. Interestingly, cells pretreated with PD98059 and cultured either in the presence or absence of 8-OH-DPAT, both had significantly increased numbers of TUNEL(+) cells. This suggests that ERK activation might antagonize both basal and 5-HT 1A receptor-induced apoptosis. In contrast, cells pretreated with SP600125 and stimulated with 8-OH-DPAT showed no increase in TUNEL(+) nuclei, suggesting that inhibition of JNK can block 5-HT 1A receptor-dependent apoptosis in these cells. In aggregate, these results suggest that JNK activation is involved in 5-HT 1A receptor-mediated DNA fragmentation, which is a hallmark of apoptosis.
In order to further verify the linkage between the 5-HT 1A receptor, JNK, and apoptosis, we incubated cells with toxin B and PTX for 48 h, stimulated with 8-OH-DPAT or vehicle, following which we measured TUNEL staining. We reasoned that because toxin B and PTX block JNK activation, that those toxins should also block 5-HT 1A receptor-mediated apoptosis. Indeed, Fig. 3D shows that PTX and toxin B each completely blocks 8-OH-DPAT-induced increases in TUNEL staining without affecting basal TUNEL staining. These results support the existence of a pathway of activation of apoptosis in CHO cells, which is shown in Fig. 4 , and can be depicted in a linear fashion as follows: 5-HT 1A receptor → PTX-sensitive G proteins → Rho family GTPase(s) → JNK → apoptosis.
Discussion
In previous work, our laboratory showed that the 5-HT 1A receptor activates ERK MAP kinase in non-neuronal cells through a pathway that involves PTX-sensitive G i/o proteins and the non-receptor tyrosine kinase c-src. We have reported in the current work that the 5-HT 1A receptor also activates c-Jun N-terminal kinase, a MAP kinase family member often associated with cell differentiation and apoptosis. JNK activation was mediated by G i/o proteins and one or more Rho family lowmolecular-weight GTPases. We also showed that the 5-HT 1A receptor induces apoptosis in CHO cells, as assayed by TUNEL staining and DNA fragmentation. This apoptotic response was mimicked by the MEK inhibitor PD98059, whereas it was completely abrogated by the JNK inhibitor SP600125.
JNK is a member of the stress-activated family of MAP kinases that is strongly activated by extracellular stimuli such as UV light, hypotonicity, and chemical toxins, while typically being only moderately activated by growth factors. These kinases have diverse functions within the cell, including roles in growth, differentiation, survival and death. The best-characterized function of JNK is its role in promoting apoptosis. Persistent activation of JNK has been associated with apoptosis in a variety of cell types, including HeLa cells [45] , endothelial cells [40] , rat mesangial cells [46] , PC12 neuronal-like cells [35] , and L929 fibrosarcoma cells [47] . Likewise, degenerating neurons from Alzheimer's disease patients have increased JNK activity [48] . However, in some cases JNK activation has been associated with cell survival. For example, JNK activation has been shown to protect myocytes from nitric-oxide-induced apoptosis and to protect HeLa cells from apoptosis after photodynamic therapy [49] . Ultimately, the effect of JNK activation on cell death and/or survival is likely sensitive to both the time course of activation and accompanying molecular signaling events within the cell.
Over the last few years, a small handful of GPCRs has been found to activate JNK, often with different functional consequences. For example, the calcium-sensing receptor was found to stimulate JNK in MDCK cells [50] , while melatonin mt1 and MT2 receptors have been shown to stimulate JNK via PTX-sensitive and-insensitive G proteins in COS-7 cells [51] . Wylie et al. reported that muscarinic acetylcholine receptors could activate JNK via a mechanism involving intracellular Ca 2+ in CHO cells [52] . We showed in this report that the 5-HT 1A receptor can also activate JNK, in this case via PTX-sensitive G i/o proteins and Rho family low molecular weight GTPases.
Because JNK activation has been widely associated with cell death and apoptosis, it is reasonable to assume that GPCRs that can activate JNK may also contribute to the apoptotic response. Although typically associated with proliferative pathways, some GPCRs have been found to play roles in apoptosis, including those for endothelin [53] , somatostatin [54, 55] , cannabinoids [56] , angiotensin II [57] , and ATP [58] . In this report, we showed that the 5-HT 1A receptor induces apoptosis, as measured by chromosomal condensation and DNA fragmentation. This effect was mimicked by PD98059, an inhibitor of the ERK MAP kinase pathway, while being completely inhibited in the presence of the JNK inhibitor, SP600125. This suggests that the 5-HT 1A receptor may simultaneously activate both pro-apoptotic and pro-survival pathways. A similar observation has been made in cardiac myocytes, in which Zhu et al. showed that the β 2 adrenergic receptor induces both a G s -mediated pro-apoptotic pathway, and a G i -PI3K-Akt-mediated anti-apoptotic pathway, although neither of these pathways was shown to involve JNK [59] . Perhaps more analogous to the 5-HT 1A receptor signaling pathway is a report by Downer et al. showing that stimulation of the cannabinoid CB1 receptor can induce neurotoxicity via JNK in cultured cortical neurons [56] . In this case, CB1 receptor stimulation resulted in the JNKdependent activation of caspase-3, an increase in the expression of the pro-apoptotic mitochondrial-associated protein Bax, and intranucleosomal DNA fragmentation. Interestingly, Adayev et al. previously showed that the 5-HT 1A receptor leads to a decrease in anoxia-induced caspase-3 activity in hippocampal HN2-5 cells via an ERK MAP kinase-and PKCα-dependent pathway [28, 29] . At first, this result may seem to be at odds with the data presented in this report. However, 5-HT 1A receptorinduced ERK activation and inhibition of caspase-3 in HN2-5 cells are mediated by phospholipase C, whereas the 5-HT 1A receptor does not efficiently stimulate phospholipase C in CHO cells. Thus, the ability of the 5-HT 1A receptor to induce ERKmediated anti-apoptotic pathways or JNK-dependent proapoptotic pathways may depend upon the relative contributions of each pathway, as well as the cell-specific presence of individual pathway components. In that regard, the finding that the MEK inhibitor, PD98059, increases basal TUNEL staining (Fig. 3C ) supports the idea that MEK and/or ERK mediate(s) anti-apoptotic effects in CHO cells. In order to confirm this relationship, we treated cells with another MEK inhibitor, U0126 (20 μM), which resulted in a statistically significant doubling of TUNEL staining (n = 3, not shown). Thus, the 5-HT 1A receptor can simultaneously activate a pro-apoptotic pathway (JNK) and an anti-apoptotic pathway (MEK/ERK) in CHO cells, the balance of which determines whether apoptosis is stimulated or not. This idea is not far-fetched, in that the MEK/ERK pathway has previously been implicated in the regulation of apoptosis [60] . The regulation of the MEK/ERK and JNK pathways by the 5-HT 1A receptor in CHO cells is depicted schematically in Fig. 4 .
The physiological relevance of the JNK pathway in 5-HT 1A receptor signaling is unclear. Most recent studies have suggested that the 5-HT 1A receptor is anti-apoptotic and neuroprotective. However, the anti-apoptotic effects of the 5-HT 1A receptor derive from multiple signal transduction pathways, depending on cell type and the concurrent cellular insult. For example, 5-HT 1A receptor-mediated protection against cyanide-induced cytotoxic hypoxia and glutamate-induced excitotoxicity in primary neuronal cell cultures from chick embryo cerebral hemispheres appears to be mediated by opening of K + channels and consequent attenuation of the depolarization required for opening of NMDA and voltage-dependent Ca 2+ channels [27] . As previously mentioned, anoxia-induced apoptosis of HN2-5 hippocampal cells is attenuated by 5-HT 1A receptor stimulated and ERK-dependent caspase-3 inhibition [28, 29] , whereas in astrocytes the 5-HT 1A receptor can apparently block apoptosis by increasing the release of the neurite extension factor S-100β [61] . However, as reported here, it is likely that the 5-HT 1A receptor stimulates a multitude of anti-apoptotic and proapoptotic pathways. The ultimate effects of the 5-HT 1A receptor depend on numerous factors including the duration of stimulation, predominance of individual pathways, and the overall cellular environment.
In conclusion, we have reported for the first time in this work that the 5-HT 1A receptor stimulates JNK MAP kinase in CHO cells. JNK stimulation was PTX-sensitive and mediated by Rho family low molecular weight GTPases. Furthermore, the 5-HT 1A receptor increased apoptosis, as detected by DNA laddering and TUNEL staining of CHO cell monolayers. 5-HT 1A receptorinduced apoptosis was accentuated by MEK/ERK inhibition, whereas it was completely blocked by maneuvers that neutralize PTX-sensitive G proteins, Rho family GTPases, and JNK. In aggregate, these results suggest that the 5-HT 1A receptor can simultaneously stimulate both ERK-dependent anti-apoptotic pathways and JNK-dependent pro-apoptotic pathways, and that the ultimate effect of 5-HT 1A receptor stimulation is probably dependent on the respective contributions of these and other pathways. 
